Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation

13Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Fifty consecutive patients with respiratory diseases who developed oropharyngeal candidiasis were assessed clinically and microbiologically before and after seven days' treatment with nystatin suspension or pastilles (a new formulation). In 45 patients in whom microbiology yielded positive results there was frequent associated use of oral corticosteroids, antibiotics, sedatives, and inhaled corticosteroid, while in a few patients atropine analogues may have predisposed to infection. Dentures were worn by 32 of the infected patients. Concomitant treatment of dentures in chronically infected patients appeared to improve the therapeutic response. Pastilles and suspension were equally efficacious both clinically and microbiologically. The potential for enhanced drug delivery to the oropharynx suggests that nystatin pastilles may be useful in patients in whom poor compliance seems likely. © 1986, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Cosgrove, R. F., & Hughes, B. O. (1986). Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation. British Medical Journal (Clinical Research Ed.), 292(6537), 1699–1700. https://doi.org/10.1136/bmj.292.6537.1699

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free